Celestica Inc

CLS remains in a Stage 4 decline, confirmed by a Support Failure pattern and decisive breakdown below the 200 DMA and shorter EMAs. Medium-term bias remains bearish as price trades beneath the 50 DMA and 200 DMA with sequential lower highs and lows. Short-term timing is unfavorable for longs—price is extended below the declining EMAs on accelerating volume and extreme oversold readings. We sell now into any relief toward the recently broken support zone, which now acts as resistance.

• ↑Q1 2026 revenue $4.05 B (+53% YoY) driven by hyperscaler orders.
• ↑Adjusted operating margin expanded to 8% in Q1, reflecting disciplined capital allocation.
• ↓Valuation premium and weak earnings yield suggest overvaluation risk.